Therefore, it is indicated that QUR could significantly release PCOS-related IR and induce uterine GLUT4 and ERα gene expression, potentially becoming a reliable drug for the treatment of PCOS combined with IR (Neisy et al., 2019). Here, SLC2A4 is linked to polycystic ovary syndrome.